Mycobacterium tuberculosis infection and the subsequent development of asthma and allergic conditions

Journal of Allergy and Clinical Immunology

Volumn 104, Issue 6, 1999, Pages 1211-1214

  Von Hertzen, Leena ^a   Klaukka, T ^b   Mattila, H ^b   Haahtela, T ^c  

^a Finnish Lung Health Association   (Finland)

^b SOCIAL INSURANCE INSTITUTION   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Allergy; Asthma; Infection; Mycobacterium tuberculosis

Indexed keywords

ADULT; ALLERGIC DISEASE; ARTICLE; ASTHMA; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; ONSET AGE; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; TUBERCULOSIS;

EID: 0033429212     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(99)70015-1     Document Type: Article

References (27)

1. 1. Asthma programme in Finland 1994-2004. Report of a working group. Clin Exp Allergy 1996;26(Suppl 1):1-24.
2. 2. Reijula K, Haahtela T, Klaukka T, Rantanen J. Incidence of occupational asthma and persistent asthma in young adults has increased in Finland. Chest 1996;110:58-61.
3. 3. Nowak D, Wichmann H-E, Magnusson H. Asthma and atopy in Western and Eastern communities - current status and open questions. Clin Exp Allergy 1998;28:1043-6.
4. 4. Holt PG. Environmental factors and primary T-cell sensitisation to inhalant allergens in infancy: reappraisal of the role of infections and air pollution. Pediatr Allergy Immunol 1995;6:1-10.
5. 5. Shaheen SO, Aaby P, Hall AJ, Barker DJP, Heyes CB, Shiell AW, et al. Measles and atopy in Guinea-Bissau. Lancet 1996;347:1792-6.
6. 6. Matricardi PM, Rosmini F, Ferrigno L, Nisini R, Rapicetta M, Chionne P, et al. Cross sectional retrospective study of prevalence of atopy among Italian military students with antibodies against hepatitis A virus. Br Med J 1997;314:999-1003.
7. 7. Shirakawa T, Enomoto T, Shimazu SI, Hopkin J. The inverse association between tuberculin responses and atopic disorder. Science 1997;275:77-9.
8. 8. Alm JS, Lilja G, Pershagen G, Scheynius A. Early BCG vaccination and development of atopy. Lancet 1997;350:400-3.
9. 9. Strannegård IL, Larsson LO, Wennergren G, Strannegård Ö. Prevalence of allergy in children in relation to prior BCG vaccination and infection with atypical mycobacteria. Allergy 1998;53:249-54.
10. 10. Andersen P. Host responses and antigens involved in protective immunity to Mycobacterium tuberculosis. Scand J Immunol 1997;45:115-31.
11. 11. Barnes PF, Mistry SD, Cooper CL, Pirmez C, Rea TH, Modlin RL. Compartmentalization of a CD4+ T lymphocyte subpopulation in tuberculous pleuritis. J Immunol 1989;142:1114-9.
12. 12. Zhan M, Gateley MK, Wang E, Gong J, Wolf SF, Lu S, et al. Interleukin 12 at the site of disease in tuberculosis. J Clin Invest 1994;93:1733-9.
13. 13. Barnes PF, Lu S, Abrams JS, Wang E, Yamamura M, Modlin RL. Cytokine production at the site of disease in human tuberculosis. Infect Immunol 1993;61:3482-9.
14. 14. Bodner C, Godden D, Seaton A, Aberdeen WHEASE Group. Family size, childhood infections and atopic disease. Thorax 1998;53:28-32.
15. 15. Härö S. Tuberculosis in Finland. Past-present-future. Tuberculosis and respiratory disease. Yearbook. Vol 18. Helsinki: The Finnish Anti-Tuberculosis Association; 1988.
16. 16. Haahtela T, Björkstén F, Heiskala M, Suoniemi I. Skin prick test reactivity to common allergens in Finnish adolescents. Allergy 1980;35:425-31.
17. 17. Robertson CT, Dalton MF, Peat JK, Haby MM, Bauman A, Kennedy JD, et al. Asthma and other atopic diseases in Australian children. Australian arm of the International Study of Asthma and Allergy in Childhood. Med J Aust 1998;168:434-8.
18. 18. Murphy BE, Shibuya K, Hosken N, Openshaw P, Maino V, Davis K, et al. Reversibility of T helper 1 and 2 population is lost after long-term stimulation. J Exp Med 1996;183:901-13.
19. 19. Matricardi PM. Infections preventing atopy: facts and new questions. Allergy 1997;52:879-82.
20. 20. Serafini U. Do infections protect against asthma and atopy? Allergy 1997;52:955-7.
21. 21. Kalyoneu AF, Stålenheim G. Serum IgE levels and allergic spectra in immigrants to Sweden. Allergy 1992;47:277-80.
22. 22. Martinez FD, Stern DA, Wright AL, Holberg CJ, Taussig LM, Halonen M. Association of interleukin-2 and interferon-γ production by blood mononuclear cells in infancy with parenteral allergy skin tests and with subsequent development of atopy. J Allergy Clin Immunol 1995;96:652-60.
23. 23. Prescott SL, Macaubas C, Smallacombe T, Holt BJ, Sly PD, Holt PG. Development of allergen-specific T-cell memory in atopic and normal children. Lancet 1999;353:196-200.
24. 24. Lee SM, Suen Y, Chang L, Bruner V, Qian J, Indes J, et al. Decreased IL-12 from activated cord versus adult peripheral blood mononuclear cells and upregulation of INF-γ, NK and LAK activity by IL-12 in cord blood mononuclear cells. Blood 1996;88:945-54.
25. 25. Kapsenberg ML, Hilkens CM, Wierenga EA, Kalinski P. The role of antigen-presenting cells in the regulation of allergen-specific T cell responses. Curr Opin Immunol 1998;10:607-13.
26. 26. Erb KJ, Holloway JW, Sobeck A, Moll H, LeGros G. Infection of mice with Mycobacterium bovis-Bacillus Calmette-Guérin (BCG) suppresses allergen-induced airway cosinophiha. J Exp Med 1998;187:561-9.
27. 27. Wang C-C, Rook GA. Inhibition of an established allergic response to ovalbumin in BALB/c mice by killed Mycobacterium vaccae. Immunology 1998;93:307-13.